论文部分内容阅读
几个资源巨大的药物化学构效关系(SAR)数据库的整合使得靶向配体的新药研发平台的构建成为可能,这种平台可探索化学结构与生物靶标之间的整体关系。人们可以从收集到的巨大的药理学数据中得到什么?是否可以理性地超越作用于单一成药基因的化合物,扩展对新药的搜索?尽管包含蛋白
The integration of several resource-rich pharmaceutical chemical structure-activity (SAR) databases made possible the construction of new drug discovery platforms targeting ligands that explored the overall relationship between chemical structures and biological targets. What can one get from the huge amount of pharmacological data collected and can it rationally go beyond compounds that act on a single drug-drug gene to extend the search for new drugs?